Wei‐Li Ling

442 total citations
16 papers, 243 citations indexed

About

Wei‐Li Ling is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Wei‐Li Ling has authored 16 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Wei‐Li Ling's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (5 papers) and T-cell and B-cell Immunology (5 papers). Wei‐Li Ling is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (5 papers) and T-cell and B-cell Immunology (5 papers). Wei‐Li Ling collaborates with scholars based in Singapore, United Kingdom and China. Wei‐Li Ling's co-authors include Samuel Ken‐En Gan, Wai‐Heng Lua, Chinh Tran-To Su, Jun-Jie Poh, Joshua Yi Yeo, David P. Lane, Anil Wipat, Birgit Eisenhaber, Peter J. Bond and Alexander Krah and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Wei‐Li Ling

16 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Li Ling Singapore 9 166 158 82 20 20 16 243
Wai‐Heng Lua Singapore 10 182 1.1× 162 1.0× 83 1.0× 19 0.9× 38 1.9× 14 257
Jun-Jie Poh Singapore 10 131 0.8× 132 0.8× 63 0.8× 11 0.6× 13 0.7× 13 236
Valérie Calabro United States 8 145 0.9× 269 1.7× 75 0.9× 35 1.8× 28 1.4× 12 353
Bernhard Aÿ Germany 10 62 0.4× 195 1.2× 52 0.6× 13 0.7× 33 1.6× 15 314
Peter S. Andersen Denmark 9 246 1.5× 224 1.4× 170 2.1× 8 0.4× 38 1.9× 9 392
Brennan Abanades United Kingdom 6 254 1.5× 262 1.7× 74 0.9× 5 0.3× 23 1.1× 9 349
Violaine Moreau France 11 156 0.9× 255 1.6× 61 0.7× 7 0.3× 16 0.8× 17 321
E. L. Johnson United States 6 128 0.8× 110 0.7× 122 1.5× 15 0.8× 23 1.1× 8 237
Lorenzo Benatuil United States 7 177 1.1× 248 1.6× 97 1.2× 4 0.2× 35 1.8× 12 402
Sneha Rangarajan United States 10 96 0.6× 100 0.6× 135 1.6× 21 1.1× 38 1.9× 10 312

Countries citing papers authored by Wei‐Li Ling

Since Specialization
Citations

This map shows the geographic impact of Wei‐Li Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Li Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Li Ling more than expected).

Fields of papers citing papers by Wei‐Li Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Li Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Li Ling. The network helps show where Wei‐Li Ling may publish in the future.

Co-authorship network of co-authors of Wei‐Li Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Li Ling. A scholar is included among the top collaborators of Wei‐Li Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Li Ling. Wei‐Li Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yeo, Joshua Yi, et al.. (2022). Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters. PubMed. 5(1). 30–41. 8 indexed citations
2.
Ling, Wei‐Li, Chinh Tran-To Su, Wai‐Heng Lua, et al.. (2022). Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L. Scientific Reports. 12(1). 6510–6510. 4 indexed citations
3.
Ling, Wei‐Li, et al.. (2022). More Than Meets the Kappa for Antibody Superantigen Protein L (PpL). Antibodies. 11(1). 14–14. 4 indexed citations
4.
Su, Chinh Tran-To, Wai‐Heng Lua, Jun-Jie Poh, et al.. (2021). Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen. Frontiers in Immunology. 12. 676048–676048. 9 indexed citations
5.
Su, Chinh Tran-To, Alexander Krah, Joshua Yi Yeo, et al.. (2020). An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 Subunit. Molecules. 25(24). 5902–5902. 7 indexed citations
6.
Ling, Wei‐Li, Wai‐Heng Lua, & Samuel Ken‐En Gan. (2020). Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles. PubMed. 3(2). 71–79. 20 indexed citations
7.
Ling, Wei‐Li, Chinh Tran-To Su, Wai‐Heng Lua, et al.. (2020). Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab Variants. Frontiers in Immunology. 11. 604318–604318. 11 indexed citations
8.
9.
Lua, Wai‐Heng, Chinh Tran-To Su, Joshua Yi Yeo, et al.. (2019). Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapy. Journal of Allergy and Clinical Immunology. 144(2). 514–523.e5. 20 indexed citations
10.
Ling, Wei‐Li, Wai‐Heng Lua, Jun-Jie Poh, et al.. (2018). Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding. Frontiers in Immunology. 9. 469–469. 31 indexed citations
11.
Lua, Wai‐Heng, Wei‐Li Ling, Joshua Yi Yeo, et al.. (2018). The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding. Scientific Reports. 8(1). 718–718. 45 indexed citations
12.
Su, Chinh Tran-To, Wai‐Heng Lua, Wei‐Li Ling, & Samuel Ken‐En Gan. (2018). Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding. Antibodies. 7(2). 20–20. 36 indexed citations
13.
Su, Chinh Tran-To, Wei‐Li Ling, Wai‐Heng Lua, Jun-Jie Poh, & Samuel Ken‐En Gan. (2017). The role of Antibody Vκ Framework 3 region towards Antigen binding: Effects on recombinant production and Protein L binding. Scientific Reports. 7(1). 3766–3766. 23 indexed citations
14.
15.
Su, Chinh Tran-To, et al.. (2016). Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance. BMC Bioinformatics. 17(S19). 500–500. 14 indexed citations
16.
Ling, Wei‐Li, Wai‐Heng Lua, & Samuel Ken‐En Gan. (2015). Fast reversible single‐step method for enhanced band contrast of polyacrylamide gels for automated detection. Electrophoresis. 36(9-10). 1224–1227. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wai‐Heng Lua Breakdown of academic impact, for papers by Jun-Jie Poh Breakdown of academic impact, for papers by Valérie Calabro Breakdown of academic impact, for papers by Bernhard Aÿ Breakdown of academic impact, for papers by Peter S. Andersen Breakdown of academic impact, for papers by Brennan Abanades Breakdown of academic impact, for papers by Violaine Moreau Breakdown of academic impact, for papers by E. L. Johnson Breakdown of academic impact, for papers by Lorenzo Benatuil Breakdown of academic impact, for papers by Sneha Rangarajan
Rankless by CCL
2026